TWD 32.0
(0.16%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 197.47 Million TWD | 6.27% |
2022 | 185.81 Million TWD | 12.88% |
2021 | 164.6 Million TWD | 14.0% |
2020 | 144.39 Million TWD | 33.14% |
2019 | 108.45 Million TWD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 141.6 Million TWD | -1.8% |
2024 Q1 | 144.19 Million TWD | -26.98% |
2023 FY | 197.47 Million TWD | 6.27% |
2023 Q2 | 162.64 Million TWD | 6.01% |
2023 Q1 | 153.42 Million TWD | 1786.95% |
2023 Q3 | 177.21 Million TWD | 8.96% |
2023 Q4 | 197.47 Million TWD | 11.43% |
2022 Q3 | 165.68 Million TWD | 0.0% |
2022 Q4 | 8.13 Million TWD | -95.09% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
SYN-TECH Chem. & Pharm. Co., Ltd. | 583.48 Million TWD | 66.156% |
Level Biotechnology Inc. | 273.2 Million TWD | 27.72% |
Sagittarius Life Science Corp | 137.82 Million TWD | -43.278% |
TaiMed Biologics Inc. | 1.32 Billion TWD | 85.128% |
GlycoNex Incorporation | 276.39 Million TWD | 28.556% |
VBI | 21.25 Million TWD | -829.232% |
GeneReach Biotechnology Corp. | 313.7 Million TWD | 37.052% |
Taiwan Advance Bio-Pharmaceutical Inc. | 514.65 Million TWD | 61.63% |
Visgeneer Inc. | 185.6 Million TWD | -6.393% |
Mycenax Biotech Inc. | 1.32 Billion TWD | 85.076% |
Sunmax Biotechnology Co., Ltd. | 732.98 Million TWD | 73.059% |
G&E Herbal Biotechnology Co., Ltd. | 119.86 Million TWD | -64.751% |
Medigen Vaccine Biologics Corporation | 2.24 Billion TWD | 91.208% |
TaiwanJ Pharmaceuticals Co., Ltd. | 6.61 Million TWD | -2883.847% |
Enimmune corporation | 173.46 Million TWD | -13.84% |
TaiRx, Inc. | 60.62 Million TWD | -225.725% |
CHO Pharma, Inc. | 110.83 Million TWD | -78.171% |
EirGenix Inc. | 1.14 Billion TWD | 82.755% |
BioLASCO Taiwan Co., Ltd. | 111.98 Million TWD | -76.343% |
Sunny Pharmtech Inc. | 512.43 Million TWD | 61.464% |
Lin BioScience, Inc. | 167.73 Million TWD | -17.731% |
BioGend Therapeutics Co., Ltd. | 93.71 Million TWD | -110.717% |
Feng Chi Biotech Corp. | 63.03 Million TWD | -213.277% |
Bio Preventive Medicine Corp. | 124.72 Million TWD | -58.32% |
Lukas Biomedical Inc. | 161.05 Million TWD | -22.608% |
RBC Bioscience Corporation | 513.08 Million TWD | 61.513% |
BiOptic Inc. | 170.56 Million TWD | -15.776% |
BRIM Biotechnology, Inc. | 42.15 Million TWD | -368.407% |
Shine-On BioMedical Co.,Ltd. | 23.25 Million TWD | -749.155% |
Great Novel Therapeutics Biotech & Medicals | 26.81 Million TWD | -636.475% |
Syngen Biotech Co.,Ltd. | 974.63 Million TWD | 79.739% |
Anti-Microbial Savior BioteQ Co., Ltd | 6.99 Million TWD | -2723.434% |
SynCore Biotechnology Co.,Ltd | 21.22 Million TWD | -830.326% |
Genomics BioSci & Tech. Co.,Ltd. | 368.33 Million TWD | 46.388% |
Neith Corporation | 17.43 Million TWD | -1032.742% |
Advagene Biopharma Co., Ltd. | 7.97 Million TWD | -2377.057% |
NaviFUS Corp. | 53.4 Million TWD | -269.789% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 481.48 Million TWD | 58.987% |
Sinew Pharma Inc. | 39.71 Million TWD | -397.233% |
Andros Pharmaceuticals Co.,Ltd | 58.03 Million TWD | -240.238% |
Greenyn Biotechnology Co., Ltd | 364.47 Million TWD | 45.821% |
Lumosa Therapeutics Co., Ltd. | 227.69 Million TWD | 13.274% |
AP Biosciences Inc | 106.65 Million TWD | -85.158% |
Medigen Biotechnology Corp. | 3.53 Billion TWD | 94.406% |
3D Global Biotech Inc. | 30.68 Million TWD | -543.626% |
Pharmosa Biopharm Inc. | 195.99 Million TWD | -0.756% |
Intech Biopharm Corporation | 1.54 Billion TWD | 87.204% |
Oneness Biotech Co., Ltd. | 866.42 Million TWD | 77.209% |
Eusol Biotech Co.,Ltd. | 9.27 Million TWD | -2028.838% |
TWi Biotechnology, Inc. | 55.81 Million TWD | -253.808% |
Ever Supreme Bio Technology Co., Ltd | 232.95 Million TWD | 15.234% |
TCI GENE Inc. | 155.54 Million TWD | -26.952% |
MegaPro Biomedical Co., Ltd | 25.5 Million TWD | -674.153% |
Senhwa Biosciences, Inc. | 46.17 Million TWD | -327.658% |
Taiwan Bio Therapeutics Co., Ltd | 328.47 Million TWD | 39.882% |
NatureWise Biotech & Medicals Corporation | 64.88 Million TWD | -204.331% |
PharmaEngine, Inc. | 91 Million TWD | -116.987% |
Savior Lifetec Corporation | 457.95 Million TWD | 56.88% |
TaiGen Biopharmaceuticals Holdings Limited | 110.94 Million TWD | -77.998% |
OBI Pharma, Inc. | 650.44 Million TWD | 69.641% |
Meribank Biotech Co., Ltd | 390.81 Million TWD | 49.472% |
Acepodia, Inc. | 384.47 Million TWD | 48.638% |
Caliway Biopharmaceuticals Co., Ltd. | 85.55 Million TWD | -130.817% |